SCHEMBL2561609

SCHEMBL2561609

CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@@H](CO)C(OP(=O)([O-])OCC[N+](C)(C)C)C(=O)CCCCCCCCCCCCCCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.66
SMN1; SMN2 Q16637 1/20 0.50
NR5A2 O00482 1/20 0.50
NR5A1 Q13285 1/20 0.50
S1PR1 P21453 2/20 0.49
RECQL P46063 1/20 0.49
MAPT P10636 2/20 0.47
FAAH O00519 1/20 0.47
HPGD P15428 1/20 0.47
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CDC25A P30304 1/20 0.44
AGTR1 P30556 1/20 0.44
AKT1 P31749 1/20 0.44
ADRA1A P35348 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1576782 1.00 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL4619498 0.99 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL4619726 0.99 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL479563 0.99 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL479610 0.99 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL37559 0.96 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL479222 0.96 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL671456 0.96 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL672371 0.96 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1
SCHEMBL479388 0.96 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220747-A1 NUCLEIC ACIDS ENCODING A CONSTITUTIVELY-ACTIVE CYCLIC GMP-AMP SYNTHASE AND IMMUNOGENIC DELIVERY VEHICLES FOR SAME CORNER THERAPEUTICS, INC. (US) 2023-11-16 WO claimed
WO-2023150758-A1 HYPERACTIVATING LIPID NANOPARTICLES CORNER THERAPEUTICS, INC. (US) 2023-08-10 WO claimed
WO-2023150757-A1 IMMUNOGENIC MRNA DELIVERY VEHICLES CORNER THERAPEUTICS, INC. (US) 2023-08-10 WO claimed
EP-4152927-A1 ORGAN PRESERVATION AND/OR PERFUSION SOLUTION XVIVO Perfusion AB (SE) 2023-03-29 EP claimed
EP-4069184-A1 LIPID VESICLES AS OXIDATIVE STRESS SENSORS Medizinische Universität Wien (AT) 2022-10-12 EP claimed
WO-2021110979-A1 LIPID VESICLES AS OXIDATIVE STRESS SENSORS MEDIZINISCHE UNIVERSITÄT WIEN (AT) 2021-06-10 WO claimed
WO-2009100348-A2 PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES ASSOCIATED WITH EYE DISEASE UAB RESEARCH FOUNDATION (US) 2009-08-13 WO claimed
EP-1562624-A4 ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY UNIV CALIFORNIA (US) 2009-07-29 EP claimed
EP-1789035-A2 ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY The Regents of the University of California-San Francisco (US) 2007-05-30 EP claimed
JP-2007512228-A 2007-05-17 JP claimed
EP-1318828-A4 ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS UNIV CALIFORNIA (US) 2005-04-27 EP claimed
WO-2005016280-A2 ORALLY ADMINISTERED SMALL PEPTIDES SYNERGIZE STATIN ACTIVITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-02-24 WO claimed
EP-1272666-A4 A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN UNIV CALIFORNIA (US) 2004-09-22 EP claimed
WO-2004034977-A2 ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-04-29 WO claimed
EP-1318828-A1 ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS The Regents of the University of California (US) 2003-06-18 EP claimed
EP-1274862-A1 CONTROL OF A GENE INDUCED BY OXIDIZED LIPIDS IN HUMAN ARTERY WALL CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-01-15 EP claimed
EP-1272666-A1 A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-01-08 EP claimed
WO-2002015923-A1 ORALLY ADMINISTERED PEPTIDES TO AMELIORATE ATHEROSCLEROSIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2002-02-28 WO claimed
WO-2001075168-A1 CONTROL OF A GENE INDUCED BY OXIDIZED LIPIDS IN HUMAN ARTERY WALL CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-10-11 WO claimed
WO-2001075170-A1 A FUNCTIONAL ASSAY OF HIGH-DENSITY LIPOPROTEIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-10-11 WO claimed